Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Loft

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Cancers|September 9, 2022
Leveraging Comprehensive Cancer Registry Data to Enable a Broad Range of Research, Audit and Patient Support ActivitiesBelinda Lee, Lucy Gately, Sheau Wen Lok, et al.
Breast Cancer Research and Treatment|January 9, 2023
Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancerMatthew Loft, Sheau Wen Lok, Richard De Boer, et al.
Internal Medicine Journal|November 18, 2024
Real-world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancerMatthew Loft, Vanessa Wong, Suzanne Kosmider, et al.
Asia-Pacific Journal of Clinical Oncology|January 24, 2022
Impact of the evolution in RAS mutation analysis in Australian patients with metastatic colorectal cancerChia Yuen Chong, Azim Jalali, Hui Li Wong, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Cancers|September 9, 2022
Leveraging Comprehensive Cancer Registry Data to Enable a Broad Range of Research, Audit and Patient Support ActivitiesBelinda Lee, Lucy Gately, Sheau Wen Lok, et al.
Breast Cancer Research and Treatment|January 9, 2023
Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancerMatthew Loft, Sheau Wen Lok, Richard De Boer, et al.
Internal Medicine Journal|November 18, 2024
Real-world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancerMatthew Loft, Vanessa Wong, Suzanne Kosmider, et al.
Asia-Pacific Journal of Clinical Oncology|January 24, 2022
Impact of the evolution in RAS mutation analysis in Australian patients with metastatic colorectal cancerChia Yuen Chong, Azim Jalali, Hui Li Wong, et al.
Pageof 2